Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China · Delayed Price · Currency is CNY 22.85
-0.60 (-2.56%)
At close: May 12, 2026
SHE:003020 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 160.59 | 163.55 | 160.6 | 226.67 | 209.25 | 172.23 |
Depreciation & Amortization | 90.48 | 90.48 | 83.15 | 45.05 | 36.04 | 36.92 |
Other Amortization | 2.77 | 2.77 | 3.34 | 2.29 | 2.18 | 1.57 |
Loss (Gain) From Sale of Assets | 0 | 0 | -0.02 | - | 2.54 | 0.03 |
Asset Writedown & Restructuring Costs | 11.09 | 11.09 | 6.43 | 0.12 | 0.39 | 3.2 |
Loss (Gain) From Sale of Investments | -27.72 | -27.72 | -13 | -28.16 | -34.9 | -11.22 |
Provision & Write-off of Bad Debts | - | - | 3.05 | 3.19 | 0.43 | - |
Other Operating Activities | 33.86 | 3.29 | 4.92 | 16.44 | 4.07 | 1.54 |
Change in Accounts Receivable | -26.74 | -26.74 | -133.76 | -211.49 | -94.2 | -29.57 |
Change in Inventory | 5.35 | 5.35 | 13.55 | -39.49 | -177.1 | 1.98 |
Change in Accounts Payable | -6.61 | -6.61 | 68.92 | 175.7 | 253.59 | -15.47 |
Change in Other Net Operating Assets | 0.3 | 0.3 | 3.24 | 10.07 | -0.3 | - |
Operating Cash Flow | 240.49 | 212.89 | 197.53 | 203.67 | 200.64 | 158.7 |
Operating Cash Flow Growth | 10.26% | 7.77% | -3.02% | 1.51% | 26.42% | -7.99% |
Capital Expenditures | -113.5 | -118.46 | -154.49 | -197.54 | -246.43 | -186.95 |
Sale of Property, Plant & Equipment | 8 | 8 | 0.49 | 0.12 | 0.33 | 0.27 |
Cash Acquisitions | - | - | -24.48 | -183.53 | - | - |
Divestitures | - | - | - | -25.15 | - | - |
Investment in Securities | -156.21 | 26.93 | -9.65 | -36 | 6.9 | -5.2 |
Other Investing Activities | 22.23 | 24.52 | 5.89 | 125.75 | 37.39 | - |
Investing Cash Flow | -239.47 | -59 | -182.23 | -314.85 | -201.8 | -191.88 |
Long-Term Debt Issued | - | - | 28.6 | 41.99 | - | - |
Total Debt Issued | 10 | - | 28.6 | 41.99 | - | - |
Short-Term Debt Repaid | - | - | -0.05 | - | - | - |
Long-Term Debt Repaid | - | - | -7.56 | -10.12 | -10.21 | -12.18 |
Total Debt Repaid | - | - | -7.61 | -10.12 | -10.21 | -12.18 |
Net Debt Issued (Repaid) | 10 | - | 20.99 | 31.87 | -10.21 | -12.18 |
Issuance of Common Stock | 0.03 | 0.03 | - | 72.08 | 27.05 | - |
Repurchase of Common Stock | - | - | -2.95 | - | - | - |
Common Dividends Paid | -128.32 | -166.16 | -80.93 | -61.28 | -64.85 | -46.32 |
Other Financing Activities | -11.82 | -13.49 | -15.44 | -6.04 | 0.06 | - |
Financing Cash Flow | -130.11 | -179.63 | -78.33 | 36.63 | -47.95 | -58.5 |
Foreign Exchange Rate Adjustments | -0.14 | -0.06 | 0.01 | 0.04 | 0.4 | -0.18 |
Net Cash Flow | -129.22 | -25.8 | -63.03 | -74.51 | -48.71 | -91.85 |
Free Cash Flow | 127 | 94.43 | 43.05 | 6.14 | -45.79 | -28.24 |
Free Cash Flow Growth | 64.51% | 119.37% | 601.38% | - | - | - |
Free Cash Flow Margin | 8.19% | 6.08% | 2.83% | 0.32% | -1.77% | -1.24% |
Free Cash Flow Per Share | 0.67 | 0.50 | 0.23 | 0.03 | -0.24 | -0.15 |
Cash Income Tax Paid | 168.57 | 168.57 | 171.81 | 149.94 | 151.93 | 116.23 |
Levered Free Cash Flow | 55.85 | 24.24 | -23.19 | 94.8 | -47.08 | -95.76 |
Unlevered Free Cash Flow | 55.94 | 24.24 | -21.99 | 95.61 | -46.52 | -94.91 |
Change in Working Capital | -30.58 | -30.58 | -50.93 | -61.94 | -19.35 | -45.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.